Search research articles
Contact Us
Filters
Showing results (1-10 of 79) with videos related to
Page
of 8
Sort By:
JACC. Cardiovascular Imaging
|
September 13, 2024
Polygenic Risk and the Progression of High-Risk Coronary Plaque
Nicholas A Marston
Current Opinion in Lipidology
|
November 5, 2025
Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent
Nicholas A Marston, André Zimerman
JACC. Clinical Electrophysiology
|
April 17, 2026
Keeping Score: Utility of Atrial Fibrillation Polygenic Risk Scores in Nonischemic Cardiomyopathy
Nicholas A Marston, Shaan Khurshid
European Heart Journal
|
October 2, 2021
Risk factors for type 2 MI: the usual suspects or guilt by association?
Michelle L O'Donoghue, Nicholas A Marston
Clinical Chemistry
|
October 19, 2023
A Tale of Two Scores: Comparing Coronary Artery Calcium and Polygenic Risk Scores for the Prediction of Coronary Heart Disease Events
Nicholas A Marston, Jason L Vassy
European Heart Journal
|
February 15, 2022
Time for a paradigm shift? Making the case for tailored selection of antiplatelet therapy
Michelle L O'Donoghue, Nicholas A Marston
Expert Review of Cardiovascular Therapy
|
September 23, 2014
The prognostic value of copeptin in patients with acute chest pain
Nicholas A Marston, Alan S Maisel
JAMA
|
November 9, 2025
Beyond Statins-Expanding the Arsenal of Lipid-Lowering Therapies
Michelle L O'Donoghue, Nicholas A Marston
Journal of the American College of Cardiology
|
May 21, 2021
The Role of Adipose Tissue in Cardiovascular Disease: Decoding its Secret Language
Michelle L O'Donoghue, Nicholas A Marston
Circulation
|
August 13, 2019
A Shocking Deficiency
Erin H Penn, Benjamin A Olenchock, Nicholas A Marston
Page
of 8
Search research articles
Search
Showing results (1-10 of 79) with videos related to
Sort By:
Page
of 8
JACC. Cardiovascular Imaging
|
September 13, 2024
Polygenic Risk and the Progression of High-Risk Coronary Plaque
Nicholas A Marston
Current Opinion in Lipidology
|
November 5, 2025
Future of angiopoietin-like protein 3 inhibitors as a therapeutic agent
Nicholas A Marston, André Zimerman
JACC. Clinical Electrophysiology
|
April 17, 2026
Keeping Score: Utility of Atrial Fibrillation Polygenic Risk Scores in Nonischemic Cardiomyopathy
Nicholas A Marston, Shaan Khurshid
European Heart Journal
|
October 2, 2021
Risk factors for type 2 MI: the usual suspects or guilt by association?
Michelle L O'Donoghue, Nicholas A Marston
Clinical Chemistry
|
October 19, 2023
A Tale of Two Scores: Comparing Coronary Artery Calcium and Polygenic Risk Scores for the Prediction of Coronary Heart Disease Events
Nicholas A Marston, Jason L Vassy
European Heart Journal
|
February 15, 2022
Time for a paradigm shift? Making the case for tailored selection of antiplatelet therapy
Michelle L O'Donoghue, Nicholas A Marston
Expert Review of Cardiovascular Therapy
|
September 23, 2014
The prognostic value of copeptin in patients with acute chest pain
Nicholas A Marston, Alan S Maisel
JAMA
|
November 9, 2025
Beyond Statins-Expanding the Arsenal of Lipid-Lowering Therapies
Michelle L O'Donoghue, Nicholas A Marston
Journal of the American College of Cardiology
|
May 21, 2021
The Role of Adipose Tissue in Cardiovascular Disease: Decoding its Secret Language
Michelle L O'Donoghue, Nicholas A Marston
Circulation
|
August 13, 2019
A Shocking Deficiency
Erin H Penn, Benjamin A Olenchock, Nicholas A Marston
Page
of 8